Cheifetz AS - Search Results

1

Biologic concentration testing in inflammatory bowel disease.

Vaughn BP, Sandborn WJ, Cheifetz AS. Vaughn BP, et al. Among authors: cheifetz as. Inflamm Bowel Dis. 2015 Jun;21(6):1435-42. doi: 10.1097/MIB.0000000000000312. Inflamm Bowel Dis. 2015. PMID: 25590953 Free PMC article. Review.

2

Infliximab: Use in Inflammatory Bowel Disease.

Travassos WJ, Cheifetz AS. Travassos WJ, et al. Among authors: cheifetz as. Curr Treat Options Gastroenterol. 2005 Jun;8(3):187-196. doi: 10.1007/s11938-005-0011-2. Curr Treat Options Gastroenterol. 2005. PMID: 15913508

3

Evidence for a genetic defect in oral tolerance induction in inflammatory bowel disease.

Kraus TA, Cheifetz A, Toy L, Meddings JB, Mayer L. Kraus TA, et al. Inflamm Bowel Dis. 2006 Feb;12(2):82-8; discussion 81. doi: 10.1097/01.MIB.0000200343.61707.52. Inflamm Bowel Dis. 2006. PMID: 16432371

4

Anti-tumour necrosis factor therapy for ulcerative colitis: evidence to date.

Thukral C, Cheifetz A, Peppercorn MA. Thukral C, et al. Drugs. 2006;66(16):2059-65. doi: 10.2165/00003495-200666160-00002. Drugs. 2006. PMID: 17112300 Review.

5

Forecasting the recurrence of ulcerative colitis: can U.C. the future?

Leffler D, Cheifetz A. Leffler D, et al. Inflamm Bowel Dis. 2008 Mar;14(3):422-4. doi: 10.1002/ibd.20311. Inflamm Bowel Dis. 2008. PMID: 17973306 No abstract available.

6

How often is a diagnosis of ulcerative colitis changed to Crohn's disease and vice versa?

Moss AC, Cheifetz AS. Moss AC, et al. Among authors: cheifetz as. Inflamm Bowel Dis. 2008 Oct;14 Suppl 2:S155-6. doi: 10.1002/ibd.20593. Inflamm Bowel Dis. 2008. PMID: 18816774 No abstract available.

7

Targeting TNF in postoperative recurrence of Crohn's disease: can we extinguish the fire before it starts?

Doherty GA, Cheifetz AS. Doherty GA, et al. Among authors: cheifetz as. Inflamm Bowel Dis. 2009 Dec;15(12):1925-6. doi: 10.1002/ibd.20973. Epub 2009 May 21. Inflamm Bowel Dis. 2009. PMID: 19462427 No abstract available.

8

Infliximab decreases colectomy rates in moderate to severe ulcerative colitis: big news or big deal?

Cheifetz AS, Rosenberg L. Cheifetz AS, et al. Inflamm Bowel Dis. 2011 Jul;17(7):1626-8. doi: 10.1002/ibd.21498. Epub 2010 Nov 4. Inflamm Bowel Dis. 2011. PMID: 21053245 No abstract available.

9

Abdominal phlegmons in Crohn's disease: outcomes following antitumor necrosis factor therapy.

Cullen G, Vaughn B, Ahmed A, Peppercorn MA, Smith MP, Moss AC, Cheifetz AS. Cullen G, et al. Among authors: cheifetz as. Inflamm Bowel Dis. 2012 Apr;18(4):691-6. doi: 10.1002/ibd.21783. Epub 2011 Jun 6. Inflamm Bowel Dis. 2012. PMID: 21648022

10

Comparative cost-effectiveness of strategies to prevent postoperative clinical recurrence of Crohn's disease.

Doherty GA, Miksad RA, Cheifetz AS, Moss AC. Doherty GA, et al. Among authors: cheifetz as. Inflamm Bowel Dis. 2012 Sep;18(9):1608-16. doi: 10.1002/ibd.21904. Epub 2011 Sep 8. Inflamm Bowel Dis. 2012. PMID: 21905173 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

230 results

Search Page

Filters